SGPHARMA EUROPE OÜ - 14574325 | Print Summary Report

keywords

  • farmaatsiatoodete hulgimüük

Employees and salaries

SGPHARMA EUROPE OÜ

Number of employees and estimated average salaries
?

SGPHARMA EUROPE OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid
Number of employees
Turnover
Per Employee
Profit
per employee
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................

Deciders and beneficiaries

SGPHARMA EUROPE OÜ

Former decision-makers
?
Bhavesh Kiritkumar Bhagat
★★★★

......

Credit Score: None

Reputation score: None

Date of birth: ......

Active relations 0

Chetan Kiritkumar Bhagat
★★★★

......

Credit Score: None

Reputation score: None

Date of birth: ......

Active relations 0

Ville Rikhard Ryynänen
★★★★

......

Credit Score: Borderline

Reputation score: 2830

Date of birth: ......

Active relations 17

SGPHARMA EUROPE OÜ

Owners
?

Former owners

Former owners

NameCredit ScorePaymentBeginningEnding
!
..................
!
..................
!
..................
!
..................
!
..................
!
..................
!
..................
!
..................

SGPHARMA EUROPE OÜ

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
0.01
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
0.01
..................
0.01
..................

Finances and assets

SGPHARMA EUROPE OÜ

Taxes paid and estimated average salaries

SGPHARMA EUROPE OÜ

Financial indicators and prognosis

SGPHARMA EUROPE OÜ

Financial raiting: "SATISFACTORY" (2023 prognosis)
2023 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

SGPHARMA EUROPE OÜ

Annual reports
Year Period Submitted Report PDF
2022 01.01.2022–31.12.2022 02.06.2023 ......
2021 01.01.2021–31.12.2021 10.01.2023 ......
2020 01.01.2020–31.12.2020 10.01.2023 ......
2019 01.01.2019–31.12.2019 30.11.2021 ......

Liabilities and debts

SGPHARMA EUROPE OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

SGPHARMA EUROPE OÜ

Reports and assets-liabilities overview 29.09.2023
?
Annual reports: ......
Annual reports: ......
Tax declarations:......

Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

SGPHARMA EUROPE OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

Latest events
...... ......

SGPHARMA EUROPE OÜ

Bailiff's enforcement proceedings as of 29.09.2023
?

Bailiff's enforcement proceedings MISSING

SGPHARMA EUROPE OÜ

Regulations of the Payment Order Department as of 29.09.2023
?

Regulations of the Payment Order Department MISSING

SGPHARMA EUROPE OÜ

Court orders in the register as of 29.09.2023
?
Logo

Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata

11.08.2022

Regulation number: Ä 50103457 / M2

Regulation status has entered into force: 11.08.2022

Date of enforcement of order or additional period: 11.08.2022

Regulation status: Jõustunud


Logo

Trahvihoiatusmäärus: majandusaasta aruanne esitamata

14.04.2022

Regulation number: Ä 50103457 / M1

Regulation status has entered into force: 14.04.2022

Date of enforcement of order or additional period: 14.04.2022

Regulation status: Jõustunud


SGPHARMA EUROPE OÜ

Decisions of the Consumer Disputes Committee as of 29.09.2023
?

Consumer disputes MISSING

SGPHARMA EUROPE OÜ

Court hearings as of 29.09.2023
?

Court hearings MISSING

SGPHARMA EUROPE OÜ

Rulings as of 29.09.2023
?

Court settlemets MISSING

SGPHARMA EUROPE OÜ

Notices and announcements as of 29.09.2023
?
Logo

Notice of liquidation proceedings of a private limited company

22.12.2022
Osaühingu likvideerimismenetluse teade
Avaldamise algus: 22.12.2022
Avaldamise lõpp: tähtajatu
SGPharma Europe OÜ (registrikood 14574325) (likvideerimisel) likvideerija avaldab teadaande äriseadustiku (ÄS) § 212 lõike 1 alusel.

Võlausaldajatele teatatakse SGPharma Europe OÜ (likvideerimisel) likvideerimismenetlusest.

Võlausaldajatel palume esitada oma nõuded nelja kuu jooksul käesoleva teate avaldamisest (ÄS § 212 lg 3). info@ryynanenconsulting.com

SGPharma Europe OÜ
Haabersti linnaosa, Tallinn, Harju maakond, Pikaliiva tn 90/2-32
E-post: info@ryynanenconsulting.com
Teadaande avaldaja kontaktandmed:
Raamatupidaja Ville Rikhard Ryynänen
Telefon: 56464458
E-post: info@ryynanenconsulting.com
Teadaande number 2017775

Marketing

Business network

SGPHARMA EUROPE OÜ

Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

SGPHARMA EUROPE OÜ

Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.